Home > Specialists > Hematology > Dr. Kai Xue (薛恺)
Specialty & Clinical Focus:
Hematology specialist at Ruijin Hospital in Shanghai, affiliated with Shanghai Jiao Tong University School of Medicine, with a clinical focus on leukemia, myelodysplastic syndromes, lymphoma, multiple myeloma, anemia, immune thrombocytopenia, and related blood disorders.
Professional Title & Qualifications:
-
Chief Physician
Hospital & Department：
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine – Department of Hematology
(address: No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, 200025)
Dr. Kai Xue (薛恺) - Hematology Specialist
Personal Biography
Dr. Kai Xue, M.D., is a Chief Physician, Professor and Doctoral Supervisor in the Department of Hematology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. His clinical work focuses on the precise diagnosis and targeted management of malignant hematologic diseases, particularly acute leukemia and myelodysplastic syndromes. He also contributes to national research projects and serves on hematology and oncology professional committees in China.
Why Choose Dr. Kai Xue for Your Hematological Care
Dr. Kai Xue combines senior clinical responsibilities at Ruijin Hospital with focused experience in acute leukemia, myelodysplastic syndromes, lymphoma and other complex blood disorders. For international patients comparing specialist-care options in China, his profile is particularly relevant when an expert review is needed before committing to travel to Shanghai. A well-organized case file—including the diagnosis, pathology and laboratory reports, prior treatment history and a clear question list—can help make the review more focused and useful.
Dr. Xue’s participation in national research projects and professional hematology and oncology committees reflects his ongoing engagement with current clinical developments. A remote specialist review can help patients better understand Dr. Xue’s opinion on the case, the questions that may require further clarification, and the information or next steps to prepare before an in-person hospital visit.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel, international patients can request MedBridgeNZ coordination for a remote specialist-review pathway with Dr. Kai Xue. We organize the medical file, coordinate translation, arrange client-authorized secure document transfer, and manage appointment communication with Ruijin Hospital and the relevant specialist office.
Once the remote review has been arranged and confirmed, Dr. Xue will review the submitted records, provide a professional opinion and recommendations, and address the patient’s submitted questions. This allows the patient to better understand the proposed clinical pathway and practical travel considerations before deciding whether to proceed to Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Kai Xue
Areas of Expertise
Common hematologic malignancies: leukemia, myelodysplastic syndromes, lymphoma, multiple myeloma, etc.
Anemia, immune thrombocytopenia, and related disorders
Verified Client Satisfaction Metrics
⭐⭐ ⭐⭐⭐ 4.9/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
4.8/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
6,400 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Chief Physician, Professor, and Doctoral Supervisor, Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Education & Training
Awards & Honors
Nominated for “Compassionate and Skilled – Outstanding Specialist Physician,” Shanghai Medical Doctor Association
Recognized as an Excellent Medical Aid Talent in Shigatse, Tibet Autonomous Region
Academic & Professional Memberships
Member, Youth Committee of the Chinese Society of Clinical Oncology (CSCO)
Member, Youth Committee of the Geriatrics Branch of the Chinese Geriatrics Society
Standing Committee Member, Professional Committee on Clinical Research and Evaluation of Antitumor Drugs, Chinese Medical Education Association
Standing Committee Member, Professional Committee on Cancer Prevention, Treatment, and Clinical Research Management, Chinese Society for Geriatric Health Care
Standing Committee Member, Anti-infection Committee of the Shanghai Association of Integrative Medicine
Vice Chairman, 12th Youth Committee of the Hematology Branch of the Shanghai Medical Association
Member, Clinical Research Committee of Antitumor Drugs, Shanghai Anti-Cancer Association
Member, Translational Medicine Committee, Shanghai Anti-Cancer Association
Guest Reviewer, Shanghai Medical Journal
Review Expert, CSCO Clinical Oncology Research Foundation
Research & Publications
Key contributor and project coordinator in national key R&D projects funded by the Ministry of Science and Technology
Expert reviewer for the Shanghai Science and Technology Database
Principal investigator for projects funded by the National Natural Science Foundation of China, the Shanghai Natural Science Foundation, the Shanghai Science and Technology Commission, the Shanghai Shenkang Clinical Research Project, and the Tibet Autonomous Region Natural Science Foundation
Selected Peer-Reviewed Publications
Xue K et al. Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma. Cell Death Dis. 2021;12(10):900. PMID: 34599153
Fei MY, Xue K, et al. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment. Blood. 2023;142(10):903–917. PMID: 37319434
Chen GL, Xue K, et al. Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study. Cancer Med. 2024;13(16):e70142. PMID: 39206577
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Kai Xue the right hematology specialist for my blood condition?
Dr. Xue’s stated clinical focus includes leukemia, myelodysplastic syndromes, lymphoma, multiple myeloma, anemia, immune thrombocytopenia and related blood disorders. Whether his expertise is the right match depends on the details of your diagnosis, prior treatment and current questions. MedBridgeNZ can coordinate preparation and transfer of your records for appointment triage and a remote specialist-review request. Following confirmation of the review arrangement, Dr. Xue will examine the submitted materials and provide an opinion on the case.
Can I request a remote specialist review with Dr. Kai Xue before travelling to Shanghai?
Yes. International patients can request MedBridgeNZ coordination for a remote specialist review before making travel arrangements. We help organize the medical file, coordinate translation, arrange client-authorized secure document transfer and manage appointment communication with the relevant Ruijin Hospital office. Once the review is confirmed, Dr. Xue will examine the submitted records, provide a professional opinion and recommendations, and respond to the patient’s prepared questions. This can help clarify the proposed pathway before deciding whether to travel to Shanghai.
What support does MedBridgeNZ provide if I travel to Ruijin Hospital in Shanghai?
MedBridgeNZ provides non-clinical medical concierge and logistics coordination for the journey to Ruijin Hospital. Support can include hospital appointment request coordination, medical invitation or visa-document coordination, travel planning, translation coordination and bilingual administrative assistance during hospital visits. Dr. Xue and the hospital team remain responsible for all clinical evaluation, diagnosis, treatment planning and medical care. Third-party hospital, specialist and travel charges are separate unless they are expressly included in writing.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis or treatment; all clinical opinions and recommendations come from the relevant hospital or licensed specialist. Hospital, specialist and other third-party medical or travel costs remain separate unless expressly stated in writing.